fbpx

Presentación de “A RANDOMIZED DOUBLED BLINDED TRIAL OF TREATMENT WITH DIAMINO-OXIDASE (DAO) IN PATIENTS WITH MIGRAINE AND DEFICIT OF ENZYME’S ACTIVITY. ” en el XXI World Congress of Neurology en Vienna

PrevNext
DR Healthcare makes available to Companies and Public and Private Institutions its Reusable Face MaskUNE-0065/2020, AFNOR and DGA